Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Last data update: Sep 26, 2022. (Total: 49614 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 1583 Records)

Next

Query Trace: all[original query]>>Cancer Genomics[Category]
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
BH Louie et al, NPJ Precision Oncology, September 22, 2022
Diet-driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
RC Simpson et al, Nature Medicine, September 22, 2022
CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice.
D'Onofrio Raffaella et al. Tumori 2022 3008916221122554
Asia-Pacific Colorectal Screening Score Combined with Stool DNA Test Improves the Detection Rate for Colorectal Advanced Neoplasms.
Xu Junfeng et al. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2022
Survival Prediction of Stomach Cancer Using Expression Data and Deep Learning Models with Histopathological Image.
Wei Ting et al. Cancer science 2022
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
Schwartzberg Lee S et al. JTO clinical and research reports 2022 3(9) 100386
Mast Cell Leukemia: Clinical and Molecular Features and Survival Outcomes of Patients in the ECNM Registry.
Kennedy Vanessa E et al. Blood advances 2022
The Utility of Breast Cancer Index (BCI) Over Clinical Prognostic Tools for Predicting the Need for Extended Endocrine Therapy: A Safety Net Hospital Experience.
Shah Sidrah et al. Clinical breast cancer 2022
Molecular Tumor Board-Assisted Care in an Advanced Cancer Population: Results of a Phase II Clinical Trial.
Miller Rachel W et al. JCO precision oncology 2022 6e2100524
The prognostic value and multiomic features of m6A-related risk signature in lung adenocarcinoma.
Wang Xiangcheng et al. American journal of translational research 2022 14(8) 5379-5393
Clinical Utility of Comprehensive Genomic Profiling Tests for Advanced or Metastatic Solid Tumor in Clinical Practice.
Ida Hanae et al. Cancer science 2022
Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
Klink Andrew J et al. Targeted oncology 2022
Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement.
Navani Neal et al. Lung cancer (Amsterdam, Netherlands) 2022 172142-153
Sputum cell-free DNA for detection of alterations of multiple driver genes in lung adenocarcinoma.
Wang Zheng et al. Cancer cytopathology 2022
Landscape of RB1 alterations in 22,432 Chinese solid tumor patients.
Xu Guanghui et al. Annals of translational medicine 2022 10(16) 885
Considerations of biomarker application for cancer continuum in the era of precision medicine.
Hung Rayjean J et al. Current epidemiology reports 2022 9(3) 200-211
Blood-based DNA methylation profiling for the detection of ovarian cancer.
Li Ning et al. Gynecologic oncology 2022
How to improve the diagnosis of prostate cancer
B Plackett, Nature, September 2022
Druggable gene alterations in Japanese patients with rare malignancy.
Ohmoto Akihiro et al. Neoplasia (New York, N.Y.) 2022 33100834
An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low)
A Prat et al, JAMA Oncology, September 15, 2022
A biomarker of response to therapy in metastatic BRAFV600E colorectal cancers
Nature Research Briefing, September 14, 2022
BRAF p.V600E genetic testing based on ultrasound-guided fine-needle biopsy improves the malignancy rate in thyroid surgery: our single-center experience in the past 10 years.
Gong Lei et al. Journal of cancer research and clinical oncology 2022
Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I.
Pang Lan-Lan et al. Cancer 2022
Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
Mattei Larissa H et al. Obstetrics and gynecology 2022
The Progress of the Specific and Rapid Genetic Detection Methods for Ovarian Cancer Diagnosis and Treatment.
Dong Kejun et al. Technology in cancer research & treatment 2022 2115330338221114497
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC).
Horak Peter et al. Genetics in medicine : official journal of the American College of Medical Genetics 2022 24(9) 1991
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm.
O'Haire Sophie et al. Targeted oncology 2022
Risk Stratification for Breast Cancer Patient by Simultaneous Learning of Molecular Subtype and Survival Outcome Using Genetic Algorithm-Based Gene Set Selection.
Koo Bonil et al. Cancers 2022 14(17)
Prevalence of ARID1A Mutations in Cell-Free Circulating Tumor DNA in a Cohort of 71,301 Patients and Association with Driver Co-Alterations.
Kurzrock Razelle et al. Cancers 2022 14(17)
Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.
Wen Kuo-Chang et al. Cancers 2022 14(17)
TOP